Introduction {#sec1_1}
============

There are over 5,000 species of mushrooms and approximately 52 species are poisonous to humans \[[@B1]\]. *Amanita* mushroom plays a major role in mycetismus and has been reported in case reports of different states in the United States. Some features that are used to identify *Amanita* species include: cream-colored gills, yellowish-brown cap, and solid stalk with round base \[[@B2]\]. *Amanita* species are frequently found in the coastal Pacific Northwest, Pennsylvania, New Jersey, and Ohio. They tend to grow in oak woodlands or in lawns next to oak trees \[[@B1], [@B2]\]. This is corroborated by case reports dating back to the 1970s (**table [1](#T1){ref-type="table"}**). Specifically, the majority of cases are located in the Northwest/Oregon and California area. There are approximately 200 species of wild mushrooms in the state of Texas, but no formal report of amatoxin poisoning has been noted in the recent literature \[[@B3]\].

Amatoxins are found within the fungal families *Amanitaceae* (genus *Amanita*), *Agaricaceae* (genus *Lepiota*), and *Cortinariaceae* (genus *Galerina*). *Amanita* species that contain amatoxins include: *Amanita phalloides*, *A. virosa*, *A. verna*, *A. ocreata*, *A. bisporigera*, *A. suballiacea*, *A. tenufolia*, and *A. hygroscopica* \[[@B4]\]. Among the *Amanita* species mushrooms, *A. phalloides* has the highest toxin content and is the most poisonous *Amanita* species. Compared to *Amanita* species, *Galerina* and *Lepiota* species mushroom have less toxin content and contribute to less detrimental health consequences in humans \[[@B4]\]. Different amatoxins are isolated and the main toxins isolated include alpha-, beta- and gamma-amanitins. The principal amatoxin that causes the majority of morbidity and mortality in the ingestion of *Amanita* mushroom is alpha-amanitin \[[@B5]\]. The toxin is absorbed across the intestine, and 60% of the absorbed toxin is excreted into the bile and undergoes enterohepatic circulation \[[@B6]\]. Unlike other poisonous mushrooms, amatoxin has a prolonged enterohepatic circulation, thus making it an important potential cause of acute liver failure. After the toxin returns to the liver and is absorbed by the hepatocytes, it inhibits RNA polymerase II and interrupts mRNA synthesis of vital structural proteins, leading to cellular necrosis \[[@B1]\].

Mycetismus or mushroom poisoning especially from *Amanita* mushrooms can be life-threatening. The major consequences from ingestion of these mushrooms can result in hepatic failure that leads to coagulopathy, encephalopathy, hepatorenal syndrome, and death \[[@B1]\]. Despite major health consequences from amatoxin mushroom poisoning, there is little literature that report amatoxin poisoning in the state of Texas. In this case report, we present a case of mycetismus from *Amanita* mushrooms near the Houston area and we also briefly discuss the pathophysiology, clinical presentation, and treatment options related to mushroom toxicity.

Case Report {#sec1_2}
===========

A 64-year-old Chinese female presented with a 1-day history of nausea and vomiting. She vomited at home 10--12 times, and the vomit was clear-looking, with no blood. She also had 6--8 episodes of watery non-bloody diarrhea. The patient had associated abdominal pain mostly in the lower abdomen, and it was crampy in nature associated with bowel movements. For her initial symptoms, she was evaluated at a local emergency room and the final working diagnosis was gastroenteritis. She was discharged on ciprofloxacin and loperamide. However, her symptoms failed to improve and she was brought to The Methodist Hospital. The patient had a past medical history of hypertension and took Chinese herbal medications for hypertension. On presentation, she had a maximum temperature of 97°F, a heart rate of 82, a blood pressure of 140/70 on sitting and 135/70 on standing, a respiratory rate of 16, and an oxygen saturation of 97%. Her physical exam was overall benign. Her initial lab showed WBC 13.5, ALT 231, AST 375, PT 15.7, INR 1.3, and negative hepatitis serologies. She also underwent an abdominal ultrasound that was within normal limits. Upon further understanding of the patient\'s history, it was found that she and her husband had picked up wild mushrooms from the sidewalk around the Houston area and cooked the mushrooms for lunch and dinner. The patient was admitted for elevation of liver enzymes and continued symptoms of nausea and vomiting. Initially, she was started on N-acetylcysteine, and the poison control center was contacted for further assistance in the patient\'s care. With the assistance of the poison control personnel, they were able to identify the mushroom from the *Amanita* species. Since admission, the patient began to have increasing levels of her liver enzymes and at one point, her ALT was 1,227 and AST was 1,378 (**fig. [1](#F1){ref-type="fig"}**). Her prothrombin and INR levels were also elevated during the hospital course (**fig. [2](#F2){ref-type="fig"}**). Due to acute liver injury, she was transferred to the medical intensive care unit for observation and higher level of care. The husband was also admitted and had similar symptoms but only mild elevations in liver enzymes that only required supportive care throughout hospitalization. The hepatology service was consulted for the acute liver injury and penicillin G was added as part of the treatment. Since starting pencillin G, the patient\'s liver function test continued to improve. She was transferred to the hospital floor on hospital day 2 and discharged the following day.

Discussion {#sec1_3}
==========

*Amanita* poisoning occurs in three separate stages \[[@B1], [@B5], [@B7]\]. The first stage or incubation stage usually occurs from 6 to 12 h after ingestion and patients usually do not present any symptoms during this time. During the second stage or gastrointestinal stage, which takes place 6--16 h after ingestion, patients develop abdominal pain, nausea, vomiting, and diarrhea for up to 24 h. During the final stage or cytotoxic stage, between 24--48 h after ingestion of the mushroom, sign and symptoms of liver damage begin to develop. During this phase, patients are free of gastrointestinal symptoms, but they can present with jaundice and hemorrhage. There are also elevations in liver tests, prothrombin time, and ammonia levels. Patients can develop hepatic encephalopathy, profound coagulopathy, and renal failure secondary to hepatorenal syndrome. During the cytotoxic stage, the prolonged enterohepatic recirculation further recycles the amatoxin through the liver multiple times. Specifically, it is excreted into the bile duct and reabsorbed through the ileum and back into the portal circulation. The recirculation of toxin inside the body further prolongs liver damage and progresses from liver injury to liver failure. In severe cases, patients may require liver transplantation for survival.

There are different options available for treating amatoxin poisoning. Multidose activated charcoal is commonly used because the toxin has a high affinity to charcoal and this helps to reduce the absorption of the toxin through the intestine \[[@B8]\]. Another agent that is commonly used in practice is penicillin G and works well in many settings. It competes with amatoxin for binding sites on serum proteins and prevents hepatocyte uptake \[[@B9]\]. Pencillin G also helps to prevent the progression of hepatic encephalopathy. In one study, the suggested dose for penicillin G is 40,000,000 U/day for adults and 1,000,000 U/day for children \[[@B10]\]. Another beta-lactam antibiotic used in the setting of amatoxin poisoning is ceftazidime and it has been shown to be more effective in some studies than penicillin G. It is usually administered 4.5 g i.v. every 2 h \[[@B10]\]. *Silybum marianum*, a silymarin complex, is a flavonolignan isolated from milk thistle and inhibits binding of alpha-amanitin to hepatocytes \[[@B5]\]. It also competes with amatoxin for transmembrane transport. One of the major compounds isolated from silymarin is silybin. Silybin dihemisuccinate is usually administered at an initial dose of 5 mg/kg by i.v. infusion over 1 h, followed by 20 mg/kg/day by continuous i.v. infusion for 6 days until the liver enzymes have normalized \[[@B10]\]. Currently, silymarin is only incorporated in food supplements and is not yet approved by the FDA as a treatment for amatoxin poisoning. It is not available in the United States. Studies have suggested that thioctic acid provides a therapeutic effect on amatoxin hepatotoxicity. The chemical serves as a free radical scavenger and prevents lipid peroxidation of cell membrane. In the clinical setting, it is administered with glucose at doses of 300 mg/kg/day in four divided doses and then 600 mg/kg/day and 50--150 mg/kg/day \[[@B10]\]. Cimetidine, a cytochrome P450 inhibitor, is an antioxidant agent used in the treatment of amatoxin poisoning. It is usually given along with penicillin G at a dose of 300 mg i.v. administered every 8 h \[[@B10]\]. N-acetylcysteine (NAC, Mucomyst) supplies sulfhydryl groups to act as a substrate for detoxifying reactive toxic intermediates \[[@B1], [@B5]\]. Vitamin C is also used to treat this group of patients and it inhibits lipid peroxidation and is used as a hepatocyte protector \[[@B9]\]. Liver transplantation is reserved for patients with encephalopathy and severe liver decompensation.

Despite many reported cases of amatoxin poisoning in other states of the United States, amatoxin poisoning has not been formally reported in Texas. According to Barbee et al. \[[@B3]\], the most common mushroom exposure in the state of Texas is *Psilocybin*, but little is known about the prevalence of *Amanita* exposure in the state of Texas. With new cases located in the state of Texas, it is increasingly important to recognize the deleterious effects of amatoxin poisoning and to be able to address the illness once the diagnosis is made. Further advances in the quality of care are necessary to better locate areas with growth of *Amanita* species and to provide adequate warning for travelers not to ingest the mushroom. Increasing collaboration with poison control centers is warranted to better diagnose and treat patients with potential amatoxin or other mushroom poisoning. Furthermore, with mushroom poisoning becoming more prevalent in the state of Texas, it is also important to educate health care providers and workers about early recognition of potential ingestion and medical disease management.

Conclusion {#sec1_4}
==========

We have presented a case of *Amanita* poisoning in the state of Texas and with new cases emerging in the state of Texas, health care providers need to be have better awareness of the serious consequences of mycetismus from *Amanita* mushrooms and to provide a proper management plan for these patients.
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###### 

Literature review of reported *Amanita* poisoning in the last 30 years in the United States

  First author           Journal, year                      Clinical presentation                                                                                                                                 Region
  ---------------------- ---------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------
                                                                                                                                                                                                                  
  French \[[@B9]\]       Clin Toxicol, 2011                 3 cases of *Amanita phalloides* mushroom poisoning in the Pacific Northwest of the US                                                                 Oregon
                                                                                                                                                                                                                  
  Cress \[[@B2]\]        Clin Gastroenterol Hepatol, 2011   1 case of *Amanita phalloides* toxicity that resulted in fulminant hepatic failure and required orthotopic liver transplantation                      Delaware
  West \[[@B11]\]        J Med Toxicol, 2009                1 case report with delayed renal failure; renal failure predominant manifestation                                                                     Oregon/Pacific Northwest
                                                                                                                                                                                                                  
  Madhok \[[@B5]\]       Minn Med, 2007                     7 Minnesota residents who developed symptoms of *Amanita* poisoning after consuming cooked mushrooms picked at a county park                          Minnesota
                                                                                                                                                                                                                  
  Madhok \[[@B6]\]       Pediatr Emerg Care, 2006           3 cases of exposure to *Amanita bisporigera*                                                                                                          Missouri
                                                                                                                                                                                                                  
  Broussard \[[@B1]\]    Am J Gastroenterol, 2001           4 cases of *Amanita virosa* ingestion with clinical presentation from complete recovery to fulminant hepatic failure                                  Ohio
                                                                                                                                                                                                                  
  Pomerance \[[@B12]\]   J Pediatr, 2000                    a 15-year-old boy with fulminant hepatic failure after drinking mushroom tea (containing *Amanita phalloides*) 4 days before admission                Florida
                                                                                                                                                                                                                  
  Mullins \[[@B13]\]     Vet Hum Toxicol, 2000              2 cases of confirmed *Amanita phalloides* poisoning treated with hemodialysis or hemoperfusion and neither contributed to the clearance of amatoxin   Oregon
                                                                                                                                                                                                                  
  Yamada \[[@B14]\]      West J Med, 1998                   10 case reports of amatoxin poisoning in Northern California                                                                                          California
                                                                                                                                                                                                                  
  Warden \[[@B7]\]       Acad Emerg Med, 1998               4 cases of *Amanita smithiana* ingestion that led to acute renal failure                                                                              Oregon/Pacific Northwest
                                                                                                                                                                                                                  
  CDC \[[@B15]\]         MMWR Morb Mortal Wkly Rep, 1997    9 cases in Northern California required hospitalization after eating *Amanita phalloides*                                                             California
                                                                                                                                                                                                                  
  O\'Brien \[[@B8]\]     Am J Gastroenterol, 1996           4 cases of *Amanita* mushroom poisoning                                                                                                               Alabama
                                                                                                                                                                                                                  
  Feinfeld \[[@B16]\]    J Toxicol Clin Toxicol, 1994       4 cases of poisoning with amatoxin-producing mushrooms in suburban Long Island                                                                        New York
                                                                                                                                                                                                                  
  Cappell \[[@B17]\]     J Clin Gastroenterol, 1992         3 residents developed gastrointestinal symptoms after ingesting *Amanita phalloides* type mushroom                                                    New Jersey
                                                                                                                                                                                                                  
  Piering \[[@B18]\]     Clin Chem, 1990                    2 cases of *Amanita virosa* mushroom poisoning                                                                                                        Wisconsin
                                                                                                                                                                                                                  
  Pinson \[[@B22]\]      Am J Surg, 1990                    5 cases of amatoxin poisoning, 4 of whom underwent liver transplantation                                                                              Oregon
                                                                                                                                                                                                                  
  Woodle \[[@B19]\]      JAMA, 1985                         orthotopic liver transplantation in a 3-year-old girl with acute hepatic failure secondary to *Amanita* poisoning                                     California
                                                                                                                                                                                                                  
  Olson \[[@B20]\]       West J Med, 1982                   10 cases of *Amanita phalloides* poisoning                                                                                                            California (San Francisco)
                                                                                                                                                                                                                  
  Becker \[[@B21]\]      West J Med, 1976                   15 cases of *Amanita phalloides* poisoning between 1964 and 1974                                                                                      California
